Drug Profile
Bupivacaine liposomal hydrogel encapsulated - Virpax Pharmaceuticals/Lipocure
Alternative Names: Bupigel; Bupisome; LBL 100; LC-400; LMVV bupivacaine; Probudur™Latest Information Update: 29 Mar 2024
Price :
$50
*
At a glance
- Originator LipoCure
- Developer LipoCure; Virpax Pharmaceuticals
- Class Analgesics; Anilides; Anti-inflammatories; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Piperidines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase I Postoperative pain
Most Recent Events
- 29 Mar 2024 US Army Institute of Surgical Research plans a head-to-head comparison study comparing probudur with free bupivacaine and EXPAREL® in mid year
- 07 Feb 2024 Pharmacodynamics data from a preclinical trial in Postoperative pain released by Virpax pharmaceuticals
- 07 Feb 2024 Pharmacodynamics data from a preclinical trial in Postoperative pain released by Virpax Pharmaceuticals